Primary care provider training in screening, assessment, and treatment of adolescent depression.
Elise M Fallucco, Robbin D Seago, Steven P Cuffe...
https://pubmed.ncbi.nlm.nih.gov/25824896/Actively Recruiting
Led by Cynthia Fontanella · Updated on 2025-08-08
2572
Participants Needed
15
Research Sites
N/A
Total Duration
Researchers are evaluating a stepped care approach called STARRS-PC Stepped Approach to Reducing Risk of Suicide in Primary Care to reduce suicide risk among youth aged 12 to 17 years receiving primary care. This study aims to compare the effectiveness of STARRS-PC against usual treatment TAU in lowering suicide attempts, suicidal thoughts, and self-injury over a 12-month period. The study also explores factors that affect how well the clinical pathway can be put into practice and sustained in primary care settings. The study is conducted over five years at 14 pediatric primary care clinics. It includes three phases treatment as usual TAU, intervention, and sustainability. During TAU, usual depression and suicide risk screening is performed. In the intervention phase, STARRS-PC is implemented, which involves universal suicide risk screening with a brief questionnaire, followed by a detailed risk assessment and care decisions based on risk level. Providers receive training and participate in interviews to identify challenges and supports for implementing the clinical care pathway. The final sustainability phase focuses on maintaining improvements without enrolling new participants. Participants include 2,572 adolescents identified at risk for suicide along with their parents or guardians. They complete interviews and questionnaires at baseline, 3, 6, and 12 months. Medical records are reviewed throughout the study. Youth outcomes measured include suicide attempts, suicidal thoughts, and non-suicidal self-injury, while family satisfaction is also assessed. Providers are evaluated on knowledge and attitudes about suicide risk management. The study includes ongoing monitoring, data collection, and a 6-month follow-up after the intervention phase for sustainability analysis.
CONDITIONS
Stepped Approach to Reducing Risk of Suicide in Primary Care
C
Cynthia Fontanella, PhD
P
Priyanka Desirazu, MSE
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Cynthia Fontanella
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Stepped Suicide Prevention Pathway (STARRS-PC) | Usual Primary Care |
|---|---|---|
| What it is | A stepped clinical pathway involving standardized screening, risk assessment, and tailored intervention steps for suicide risk within primary care, implemented by providers for at-risk adolescents. | Standard primary care management, which may include assessment and referral but lacks a structured, stepped suicide prevention pathway. |
| Role in the study | Investigational strategy being tested to determine if a standardized, stepped protocol in primary care can improve suicide prevention outcomes. | Comparator group for evaluating the added value of the stepped suicide prevention approach. |
| Primary use or aim | To reduce suicide risk and prevent suicidal behaviors in youth by systematically identifying at-risk individuals and delivering stepped interventions in primary care. | To provide routine management of adolescent suicide risk following each clinic’s usual practice, often without a standardized suicide prevention protocol. |
| How it is delivered | Stepped pathway includes universal screening, assessment of suicide risk with validated tools, provider training, and matching intervention steps (such as monitoring, safety planning, enhanced referral) based on risk level, all integrated into routine primary care visits for eligible youth. | Management varies by provider and may include standard evaluation, individual clinical judgment, and referral outside of a formalized, structured protocol for youth suicide risk. |
| Evidence status | Effectiveness of the stepped pathway for suicide prevention in primary care is under clinical investigation and has not yet been established by conclusive trial results. | Usual primary care is widely used and recommended for youth at suicide risk, but structured suicide prevention in primary care is not yet universally implemented; published literature supports the need for improved protocols. |
| Important limitations | Success depends on provider engagement, consistent protocol adherence, training, and integration with mental health services. The stepped approach is new to many primary care settings, and real-world effectiveness may vary. | Clinical care outside a standardized protocol can be inconsistent. Some youth may not be systematically screened or may miss evidence-based interventions due to care variation. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At baseline
Participants complete initial assessments including interviews and questionnaires to establish baseline measures.
1 visit (in-person)
Duration - 6 to 26 months
Participants receive usual and customary care with depression and suicide risk screening using PHQ-9, establishing baseline rates of suicide risk detection.
Visits as part of routine primary care
Duration - 11 to 30 months
Participants undergo a clinical pathway including universal suicide risk screening with ASQ, risk assessment with BSSA, and tailored clinical care based on risk level.
Multiple visits for suicide risk screening and follow-up assessments at 3, 6, and 12 months post-baseline
Duration - 12 months post-baseline
Participants complete follow-up assessments at 3, 6, and 12 months after baseline to track outcomes including suicide attempts, suicidal ideation, and family satisfaction.
3 visits (at 3, 6, and 12 months)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
SEQUENTIAL
Primary Purpose
PREVENTION
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Elise M Fallucco, Robbin D Seago, Steven P Cuffe...
https://pubmed.ncbi.nlm.nih.gov/25824896/Khyati Brahmbhatt, Brian P Kurtz, Khalid I Afzal...
https://pubmed.ncbi.nlm.nih.gov/30384966/D A Brent, J A Perper, G Moritz...
https://pubmed.ncbi.nlm.nih.gov/8496115/K Kroenke, R L Spitzer, J B Williams
https://pubmed.ncbi.nlm.nih.gov/11556941/Janus Christian Jakobsen, Christian Gluud, Jørn Wetterslev...
https://pubmed.ncbi.nlm.nih.gov/29207961/Anna K McDowell, Timothy W Lineberry, J Michael Bostwick
https://pubmed.ncbi.nlm.nih.gov/21709131/A R Stiffman, S M Horwitz, K Hoagwood...
https://pubmed.ncbi.nlm.nih.gov/10939232/S M Horwitz, K Hoagwood, A R Stiffman...
https://pubmed.ncbi.nlm.nih.gov/11474056/Rodger S Kessler, Andrea Auxier, Juvena R Hitt...
https://pubmed.ncbi.nlm.nih.gov/27736110/Alex R Kemper, Cody A Hostutler, Kristen Beck...
https://pubmed.ncbi.nlm.nih.gov/34099503/Cynthia Fontanella
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborating Sponsor